Trial Engage Digital Toolkit for Decentralized Trials and Registries

Rx.Health supports clinical trials, registries, and post-marketing surveillance through its e-PRO library and API-driven platform. Researchers can track the use of novel tools, elicit feedback from patients at specific times and measure outcomes at specific end-points.

Pharmaceutical companies can integrate their existing digital assets into the Rx.Health platform so they can be released to multiple sites simultaneously for maximum adoption.

Pre-Built Digital Toolkits with Clinical Intelligence

  • Digital Front door
  • DTx and Monitoring
  • Decentralized Trials

Open FHIR-based Architecture

  • Supports Customizable Toolkits

  • Create new DTx Assets

  • AI Integration

Exponential ROI by Enhancing Experience

  • Automation
  • Monitoring Across Fee for Service

  • Value based care

Our success stories from our more than 250+ Digital Navigation Program library

100,000+

Content and DTx

230

Patients Enrolled in
single day

40%

Readmission Reduction with RPM

66%

Uncontrolled Asthma Management

50%

Less aborted colonoscopies

ACC

Transformation

Millions

Of dollars/trial lost due to lack of engagement

9 out of 10

Trials are delayed because of recruitment

80%

Eligible participants
are never outreached

Digital Tx

Prescription for IBD

 

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!

To Get Access To This Content

Submit your details:

You have Successfully Subscribed!